Core Scientific CORZ NASDAQ

The $3.3 billion Senior Secured Notes offering (claim 1834) was announced with full terms on May 5, 2026—7.75% interest rate, $3.24 billion net proceeds, 11.5% principal amortization through 2031—and marked as withdrawn by September 2, 2026 with no public revision statement explaining the cancellation or any alternative financing structure. The syndication fees for the March 5, 2026 term loan facility (claim 2257) were promised to commence by June 18, 2026 but transitioned to delayed status on September 2 without a disclosed postponement or rate adjustment announcement. Three executive appointments—Jorge Ray as Principal Accounting Officer (claim 1847, promised May 7), Steve Smith to the Board (claim 1301, promised May 26), and Mark Adams to the Board (claim 63, promised July 29)—all slipped past their promised dates and are now marked delayed, suggesting internal execution headwinds that have not been publicly addressed. The Bridge Facility repayment (claim 1837) promised for May 6, 2026 is similarly delayed with no disclosed amendment or refinancing disclosure. The Polaris DS LLC acquisition (claim 1826) was announced with merger agreement and purchase price details ($421 million) plus lease termination contingencies through June 2028, but no subsequent updates on deal closure, earnout timing (claim 1830, contingent payment promised by December 31, 2026), or any material integration milestones have appeared in the record, leaving material acquisition execution status silent.

The company disclosed on 2026-03-30 a CoreWeave partnership with $10 billion in projected revenue over 12 years (claim 2144) and 70 MW of additional capacity (claim 2142), citing these as inflection-point evidence (claim 2153); it later disclosed on 2026-07-28 that annualized colocation revenue run rate is $635 million (claim 173) and total contracted customer revenue across all customers is $24 billion (claim 165). What has not been said is the ramp schedule—how many of the $24 billion is realized in 2026, 2027, and 2028, and whether CoreWeave and AMD revenues are being double-counted or are genuinely additive; a first-year analyst would ask for quarterly revenue guidance by customer and contract.

The company disclosed on 2026-07-27 that AMD holds a capacity reservation option for 2.0 gigawatts with an exercise deadline of 2028-12-28 (claim 167) and that AMD received 30 million warrant shares expiring 2031-07-27 (claim 136); what has not been said is the strike price of the warrants, the option exercise price and exclusivity terms of the 2.0 GW reservation, and whether either instrument contains customer-favorable dilution protection or termination rights—information material to valuing the concessions made to retain this customer.

The company announced on 2026-05-05 a proposed $3.3 billion senior secured notes offering promised by 2031-05-15 at 7.75 percent interest with $3.24 billion estimated net proceeds (claims 1834–1838), but this offering was withdrawn by 2026-09-02 (claim 1834 status withdrawn); the withdrawal came after the 2026-07-28 announcement of $24 billion in contracted customer commitments. What has not been said is why the financing was withdrawn—whether due to adverse market conditions, reduced capital needs following new customer contracts, or concerns about debt serviceability—and which debt or equity source now funds the capital expenditure plan disclosed through 2028.

The company appointed Jorge Ray as Principal Accounting Officer on 2026-05-04, disclosing a $400,000 annual base salary, 40 percent target bonus, $600,000 RSU grant, and $193,000 signing bonus (claims 1848–1851); what has not been said is the compensation package of the predecessor PAO, any related-party relationship between Ray and the company or board, and the justification for the $193,000 signing bonus for an officer appointment—standard proxy disclosure would include prior-year officer compensation for comparison.

The company identified specific facility locations and customer commitments on 2026-07-27: AMD leases for 377 MW at Pecos, Muskogee, and Hunt County (claim 132), Neocloud for 152 MW at Auburn and Dalton Phase 3 (claim 133), and a Pecos campus target of 1.5 GW gross capacity with deliveries through 2027-06-30 (claims 2052–2053, claim 168). What has not been said is the grid interconnection point, the name of the utility or utilities providing power, the megawatt-per-quarter delivery schedule, confirmation of available electrical capacity from the utility, and any power purchase agreements—items essential to validating capacity targets and confirming no supply-chain chokepoint exists at the utility level.

The company disclosed on 2026-05-05 the acquisition of 40 acres at Muskogee with 440 MW electrical capacity (claims 1827–1828) for a purchase price of $421 million (claim 1829) in the Polaris DS merger (claim 1826); simultaneously it disclosed a bridge facility with repayment promised by 2026-05-06 (claim 1837) that has been delayed as of 2026-09-02. What has not been said is the allocation of the $421 million purchase price across land, buildings, and power infrastructure; the electrical utility providing the 440 MW; whether 40 acres is sufficient for the planned expansion; the principal amount of the bridge facility; the reason for the four-month delay in bridge repayment; and the strategic rationale for the acquisition beyond the 440 MW capacity addition.

Core Scientific's disclosed customer portfolio consists of two explicitly named, legally binding lease and capacity agreements with no evidence of MOUs, LOIs, or preliminary discussions among the major contracts reviewed. Both CoreWeave and Advanced Micro Devices (AMD) are identified by name across multiple sources dating back to March 2026 (claim 2142) and July 2026 (claims 132, 133, 163) respectively, with executed Lease Agreements forming the foundation of each relationship. Neocloud, a lessee under the same structure, is similarly named (claim 133). The only unnamed reference appears in claim 707, which alludes to "other technology-related partners" without identification—a formulaic hedge providing no material disclosure. Block, mentioned for ASIC chip procurement (claim 2591), is also explicitly named.

Counterparty concentration has evolved into a stark duopoly. CoreWeave began as the sole anchor customer, expanding from a baseline of approximately 590 megawatts across five sites documented in March 2026 (claims 2143, 2668). By July 2026, AMD entered with ~377 MW (claim 132) plus Neocloud's 152 MW (claim 133), establishing AMD's foothold at approximately 529–530 MW. By August 2026, this crystallized into a two-customer structure: CoreWeave at ~590 MW under 12-year take-or-pay contracts (claims 1611, 2604) and AMD at ~530 MW under 15-year agreements (claims 1612, 1889). These two counterparties account for roughly 1,120 MW of disclosed contracted capacity, representing extreme customer concentration.

Revenue disclosures generally reconcile with announced capacity. CoreWeave's 12-year contracts are claimed to generate over $10 billion in total revenue (claims 2621, 2653) at approximately $850 million in annualized run rate (claim 2622), which extrapolates to $10.2 billion—internally consistent. A 200 MW subset of CoreWeave contracts is separately valued at $3.5 billion over 12 years (claim 2528), averaging $290 million annually. AMD's 15-year agreements are estimated at more than $14 billion in base contracted revenue (claim 691), or roughly $933 million per year. Both contracts employ take-or-pay structures (claims 2610, 2695), anchoring revenue certainty. However, AMD's reservation rights extending to 2.5 GW (claims 1888, 2731) introduce material upside optionality beyond the signed 529 MW, creating asymmetry between announced and legally committed capacity.

Core Scientific's announced capacity has scaled from 350 MW energized in March to 1.4 GW gross and 1.0 GW client-billable (claims 2627, 2628), with a stated pipeline reaching 3.3 GW potential. Yet delivery timelines have slipped materially. The CoreWeave partnership—initially 70 MW (claim 2142, March)—expanded to 590 MW promised, but interim targets failed. The company committed to 250 MW by end-2025 (claim 2645) and 382 MW by mid-2026 (claim 2578); only 120 MW sits energized as of September (claim 2647). The revised target of 500 MW additional in 2H 2026 (claim 2579) lacks public validation through grid interconnection data or construction reports.

The portfolio shows capacity restatements without explicit delay acknowledgement. September filings detail site-specific targets—Denton 260 MW, Dalton 175 MW, Austin 20 MW—yet energization status remains unverified. The AMD partnership, structured as $14 billion in take-or-pay revenue agreements (claims 1889, 2610), anchors 2.5 GW in capacity reservation (claim 1888), differentiating contracted demand from promotional guidance. AMD's actual drawdown timing remains opaque.

The Polaris DS acquisition closed at $444 million (claim 1886), adding 440 MW at Muskogee (claim 1828), and the company deployed $444 million on power infrastructure (claim 1885), demonstrating real capex. Against this sits the failed CoreWeave $9 billion all-stock merger (claim 690, promised by 2025-07-01), signaling execution risk. The pivot to contractual capacity implies greater reliance on third-party infrastructure and partner compliance.

Over ninety days, monitor CoreWeave's 500 MW energization claim against actual 2H 2026 grid data. Track interconnection queue advancement at Denton, Dalton, and new sites—public records validating construction. Assess whether Muskogee's 1.5 GW expansion (claim 1887) advances beyond planning. The Hunt County site (285 MW by 2029, claim 2656) is too distant for near-term credibility. Focus on whether current-year targets hold.

Core Scientific's capital trajectory from March through September 2026 reads as a pivot from failed large-scale refinancing to opportunistic assembly of smaller, disparate facilities. The firm opened with a $500 million senior secured term loan (claim 2251), immediately drawn, then rapidly amended to $1 billion (claim 2230) by late March. In April, it announced a $3.3 billion senior secured notes offering (claim 2054) explicitly earmarked for debt repayment (claim 2055), but withdrew that offering by May (claim 1834) without disclosed market conditions. The pivot from refinancing to growth-stage deployment is material: instead, it closed a $444 million acquisition of Polaris DS (claim 40) in August, modestly higher than the $421 million purchase price announced in May (claim 1829).

The financing mix itself is telling. After the notes withdrawal, Core Scientific layered in a $1 billion Morgan Stanley facility (claim 1036, initial $500M tranche per claim 1037) at SOFR plus 200 basis points, alongside a smaller $600 million senior secured credit facility (claim 2729), plus an AMD warrant issuance (claim 136) worth $30 million in apparent equity. By September, the firm disclosed $1.085 billion in senior unsecured convertible notes outstanding—$460 million (claim 2601) and $625 million (claim 2602)—suggesting convertible debt was the path when large-cap debt markets closed. A mandatory convertible conversion (claim 2540) eliminated $234 million of prior equity obligations.

Deployment tells a different story from stated intent. The withdrawn $3.3B offering was pitched for debt paydown, yet H1 capital expenditures reached $954 million (claim 698), with $750 million committed to CoreWeave data center buildout (claim 2624) and $104 million to an AMD capacity expansion (claim 2625). Operating losses ran $78 million in Q2 (claim 697) on $164 million revenue (claim 694), despite a $80 million gross profit (claim 695), implying overhead and interest consume 47 percent of gross margin. Contracted customer revenue stood at only $24 million (claim 1614), creating a 40-to-1 ratio of capex to existing revenue commitments.

A reader should watch whether CoreWeave capex generates the $850 million annualized colocation revenue (claim 2677) management projects, whether the AMD contract scales beyond $14 million base revenue (claim 164) into the $24 billion total potential cited (claim 1606), and whether $300 million in expected restricted cash release (claim 2735) sustains liquidity through debt maturities. The pattern—failed large refinancing followed by rapid-fire smaller facilities and convertibles—requires explanation of market access or credit conditions between May and August.